| [1] |
Chen W, Zheng R, Baade P D, et al. Cancer statistics in China, 2015. CA Cancer J Clin, 2016.
|
| [2] |
Kemeny N. The management of resectable and unresectable liver metastases from colorectal cancer. Curr Opin Oncol, 2010, 22(4): 364-373.
|
| [3] |
Siegel R, Ma J, Zou Z, et al. Cancer statistics, 2014. CA Cancer J Clin, 2014, 64(1): 9-29.
|
| [4] |
Abdalla E K, Vauthey J N, Ellis L M, et al. Recurrence and outcomes following hepatic resection, radiofrequency ablation, and combined resection/ablation for colorectal liver metastases. Ann Surg, 2004, 239(6): 818-825, 825-827.
|
| [5] |
Adam R, De Gramont A, Figueras J, et al. The oncosurgery approach to managing liver metastases from colorectal cancer: a multidisciplinary international consensus. Oncologist, 2012, 17(10): 1225-1239.
|
| [6] |
Zong C, Lu S, Chapman A R, et al. Genome-wide detection of single-nucleotide and copy-number variations of a single human cell. Science, 2012, 338(6114): 1622-1626.
|
| [7] |
Pachmann K, Clement J H, Schneider C P, et al. Standardized quantification of circulating peripheral tumor cells from lung and breast cancer. Clin Chem Lab Med, 2005, 43(6): 617-627.
|
| [8] |
Heerboth S, Housman G, Leary M, et al. EMT and tumor metastasis. Clin Transl Med, 2015, 4: 6.
|
| [9] |
Yu M, Bardia A, Wittner B S, et al. Circulating breast tumor cells exhibit dynamic changes in epithelial and mesenchymal composition. Science, 2013, 339(6119): 580-584.
|
| [10] |
Leon S A, Shapiro B, Sklaroff D M, et al. Free DNA in the serum of cancer patients and the effect of therapy. Cancer Res, 1977, 37(3): 646-650.
|
| [11] |
Fujiwara K, Fujimoto N, Tabata M, et al. Identification of epigenetic aberrant promoter methylation in serum DNA is useful for early detection of lung cancer. Clin Cancer Res, 2005, 11(3): 1219-1225.
|
| [12] |
Kim S J, Masago A, Tamaki Y, et al. A novel approach using telomerase-specific replication-selective adenovirus for detection of circulating tumor cells in breast cancer patients. Breast Cancer Res Treat, 2011, 128(3): 765-773.
|
| [13] |
Hyun K A, Lee T Y, Jung H I. Negative enrichment of circulating tumor cells using a geometrically activated surface interaction chip. Anal Chem, 2013, 85(9): 4439-4445.
|
| [14] |
Stott S L, Hsu C H, Tsukrov D I, et al. Isolation of circulating tumor cells using a microvortex-generating herringbone-chip. Proc Natl Acad Sci U S A, 2010, 107(43): 18392-18397.
|
| [15] |
Vona G, Sabile A, Louha M, et al. Isolation by size of epithelial tumor cells : a new method for the immunomorphological and molecular characterization of circulatingtumor cells. Am J Pathol, 2000, 156(1): 57-63.
|
| [16] |
Zheng S, Lin H, Liu J Q, et al. Membrane microfilter device for selective capture, electrolysis and genomic analysis of human circulating tumor cells. J Chromatogr A, 2007, 1162(2): 154-161.
|
| [17] |
Diehl F, Schmidt K, Choti M A, et al. Circulating mutant DNA to assess tumor dynamics. Nat Med, 2008, 14(9): 985-990.
|
| [18] |
Rahbari N N, Aigner M, Thorlund K, et al. Meta-analysis shows that detection of circulating tumor cells indicates poor prognosis in patients with colorectal cancer. Gastroenterology, 2010, 138(5): 1714-1726.
|
| [19] |
Cohen S J, Punt C J, Iannotti N, et al. Relationship of circulating tumor cells to tumor response, progression-free survival, and overall survival in patients with metastatic colorectal cancer. J Clin Oncol, 2008, 26(19): 3213-3221.
|
| [20] |
Nole F, Munzone E, Zorzino L, et al. Variation of circulating tumor cell levels during treatment of metastatic breast cancer: prognostic and therapeutic implications. Ann Oncol, 2008, 19(5): 891-897.
|
| [21] |
Scher H I, Jia X, de Bono J S, et al. Circulating tumour cells as prognostic markers in progressive, castration-resistant prostate cancer: a reanalysis of IMMC38 trial data. Lancet Oncol, 2009, 10(3): 233-239.
|
| [22] |
Diehl F, Schmidt K, Choti M A, et al. Circulating mutant DNA to assess tumor dynamics. Nat Med, 2008, 14(9): 985-990.
|
| [23] |
Yang M J, Chiu H H, Wang H M, et al. Enhancing detection of circulating tumor cells with activating KRAS oncogene in patients with colorectal cancer by weighted chemiluminescent membrane array method. Ann Surg Oncol, 2010, 17(2): 624-633.
|
| [24] |
Kaifi J T, Kunkel M, Das A, et al. Circulating tumor cell isolation during resection of colorectal cancer lung and liver metastases: a prospective trial with different detection techniques. Cancer Biol Ther, 2015, 16(5): 699-708.
|